This paper examines how a radical technological innovation affects alliance formation of firms and subsequent network structures. We use longitudinal data of interfirm R&D collaborations in the biopharmaceutical industry in which a new technological regime is established. Our findings suggest...

When inter-firm alliance contracts are inevitably incomplete and include interdependent, though to some extent non-contractible, activities, contracting parties can device coordination mechanisms that both facilitate guidance of the alliance through communication and promote mutual adaptability...

Objective: The article aims to verify the development of innovation cooperation in the biopharmaceutical (biotech, pharma) industry in Central and Eastern Europe (CEE) taking into account the directions of innovation cooperation. I will try to verify the importance of location in innovation...

Building on the recent theoretical notion that a firm's alliance management capability can be a source of competitive advantage (Dyer and Singh, 1998; Ireland, Hitt, and Vaidyanath, 2002), we empirically investigate the effect of alliance-specific and firm-level factors on a high-technology...

We use a simple model of collaborative innovation to structure an empirical analysis of minority equity links in biotechnology alliances between clients and R&D firms. In the model, an equity link is an investment in information acquisition: it improves the ability of the client to learn about...

Alliances for new product development have been studied extensively in the operations management literature. Alliances between an innovator and a partner create value by utilizing their complementary capabilities. In this paper, we seek to understand what drives the alliance structure: The...